Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya

PLoS ONE(2021)10.1371/journal.pone.0243167Source: DataRank Database

Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya is a research paper published in PLoS ONE (2021). On theSindex it has a DataRank of 0.560. It has been cited 12 times, with 9 citing works in its 1-hop citation network.

N/A

0.560DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access12 citations · 9 citing works in its network

Download PDF

Cite:

Linked data & code

nct

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT01864603

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.37)OA: goldTopics (127)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 69%Citation Network 31%

Base Score Contribution

0.385

From this paper's citation signal

Citation Network Contribution

0.176

From 8 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 9 citers.

Prevalence of alcohol use by gender and HIV status in rural Uganda
PLoS ONE202410 citations43 referencesContributes 0.056
Optimizing HIV case identification: investigating client characteristics predictive of HIV positivity from provider-initiated testing (PITC) in central Kenya
BMC Health Services Research20232 citations24 referencesContributes 0.046
Health and economic impact of oral PrEP provision across subgroups in western Kenya: a modelling analysis
BMJ Global Health20253 citations37 referencesContributes 0.037
Application of targeted maximum likelihood estimation in public health and epidemiological studies: a systematic review
Annals of Epidemiology202337 citations228 referencesContributes 0.016
Addressing an HIV cure in LMIC
Retrovirology202119 citations195 referencesContributes 0.015

Authors (16)

Maya L. Petersen ORCID,Elizabeth A. Bukusi ORCID,Moses R. Kamya ORCID,Florence Mwangwa ORCID,Jane Kabami ORCID

Live enrichment

PubMed:33544717 PMC:PMC7864429 OpenAlex:https://openalex.org/W3128155386

National Institutes of Health

Grant: NIH UM1AI068636

National Institutes of Health

Grant: NIH U01AI099959

NIAID NIH HHS

Grant: U01 AI099959

NIAID NIH HHS

Grant: UM1 AI068636

National Institutes of Health

Grant: 3UM1AI068636-19SC

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

National Institutes of Health

Grant: 3U01AI099959-03S1

Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START)

FWCI

0.37

Citation Percentile

0.6%

Citation Trend

2021

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0243167&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0243167&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0243167

journalhttps://doi.org/10.1371/journal.pone.0243167

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33544717

Fields of Study

HIV/AIDS Research and InterventionsHIV Research and TreatmentHIV/AIDS drug development and treatment0302 clinical medicine03 medical and health sciencesAdolescentAdultAnti-HIV AgentsFemaleHIVHIV InfectionsHIV TestingHumansIncidenceKenyaMaleMass ScreeningMiddle AgedRisk FactorsRural PopulationSex FactorsUgandaYoung Adult

MeSH Terms

HIV TestingAdolescentAdultFemaleHIVHumansKenyaMaleMass ScreeningMiddle AgedRisk FactorsRural PopulationSex FactorsUgandaHIV InfectionsIncidenceAnti-HIV AgentsYoung Adult

Keywords

Human immunodeficiency virus (HIV)MedicineVirologyEnvironmental healthPrevention (rcdc)MaleRural PopulationAlcohol Use and Health (rcdc)General Science & Technology (science-metrix)HIV InfectionsHIV TestingAlcohol Use and HealthSubstance MisuseClinical Research (rcdc)Risk FactorsINFECTIONMass ScreeningUganda32 Biomedical and Clinical Sciences (for-2020)Male (mesh)42 Health Sciences (for-2020)Humans (mesh)Young Adult (mesh)Substance Misuse (rcdc)3 Good Health and Well Being (sdg)IncidenceQRWOMENMENKenya (mesh)Middle AgedAlcoholismInfection (hrcs-hc)Infectious DiseasesAGE-DISPARATEHIV/AIDSRural Population (mesh)FemaleSEXPublic HealthUganda (mesh)Behavioral and Social Science (rcdc)Research ArticleAdultAFRICAAdolescentGeneral Science & TechnologyAnti-HIV AgentsScienceClinical SciencesClinical Trials and Supportive ActivitiesClinical Trials and Supportive Activities (rcdc)610613HIV Infections (mesh)HIV (mesh)Young AdultRISK BEHAVIORSex FactorsClinical ResearchIncidence (mesh)Risk Factors (mesh)Health SciencesBehavioral and Social Science4206 Public Health (for-2020)Middle Aged (mesh)HumansOther Medicine and Health Sciences3202 Clinical Sciences (for-2020)HIV/AIDS (rcdc)Biomedical and Clinical SciencesPreventionAdolescent (mesh)HIV Testing (mesh)HIVKenyaAnti-HIV Agents (mesh)Good Health and Well BeingInfectious Diseases (rcdc)Female (mesh)Adult (mesh)Mass Screening (mesh)Sexually Transmitted InfectionsSex Factors (mesh)Sexually Transmitted Infections (rcdc)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 5: 5. Gender equalitySDG 0: Good health and well-being